{"title":"CeO2/BiYO3 photocatalyst for the degradation of tetracycline under visible light irradiation","authors":"Tharit Lerdwiriyanupap, Anurak Waehayee, Thitipong Choklap, Jeeranan Prachanat, Hideki Nakajima, Tammanoon Chankhanittha, Teera Butburee, Theeranun Siritanon","doi":"10.1016/j.ceramint.2024.10.126","DOIUrl":null,"url":null,"abstract":"Photocatalysis has received extensive attention as a promising method for reducing antibiotic contamination in water. In this study, we prepared and investigated the photodegradation efficiency of the CeO<sub>2</sub>/BiYO<sub>3</sub> system, using tetracycline (TC) as a model pollutant. The composites demonstrated significantly higher photocatalytic activity compared to pure BiYO<sub>3</sub> and CeO<sub>2</sub>, demonstrating their potential as effective photocatalysts. A detailed investigation of the band potentials indicated that the two semiconductors form a type II heterojunction, enhancing charge separation. Furthermore, the presence of the Ce<sup>3+</sup>/Ce<sup>4+</sup> redox couple serves as an electron trap site, improving the photocatalytic performance by reducing electron-hole recombination. The catalyst achieved peak efficiency only during the first cycle. However, a simple annealing process effectively regenerated the catalyst to its original efficiency, suggesting that the CeO<sub>2</sub>/BiYO<sub>3</sub> composite can be reused with minimal loss of activity. Additionally, we examined the distinct photodegradation mechanisms of pure BiYO<sub>3</sub> and the CeO<sub>2</sub>/BiYO<sub>3</sub> composite. Our results provide insights into how the formation of heterostructures influences photocatalytic processes. These findings are valuable for the future design and development of related heterostructure photocatalysts, aiming to enhance their efficiency for the degradation of various pollutants.","PeriodicalId":48790,"journal":{"name":"The Lancet Diabetes & Endocrinology","volume":"9 1","pages":""},"PeriodicalIF":44.0000,"publicationDate":"2024-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Lancet Diabetes & Endocrinology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.ceramint.2024.10.126","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0
Abstract
Photocatalysis has received extensive attention as a promising method for reducing antibiotic contamination in water. In this study, we prepared and investigated the photodegradation efficiency of the CeO2/BiYO3 system, using tetracycline (TC) as a model pollutant. The composites demonstrated significantly higher photocatalytic activity compared to pure BiYO3 and CeO2, demonstrating their potential as effective photocatalysts. A detailed investigation of the band potentials indicated that the two semiconductors form a type II heterojunction, enhancing charge separation. Furthermore, the presence of the Ce3+/Ce4+ redox couple serves as an electron trap site, improving the photocatalytic performance by reducing electron-hole recombination. The catalyst achieved peak efficiency only during the first cycle. However, a simple annealing process effectively regenerated the catalyst to its original efficiency, suggesting that the CeO2/BiYO3 composite can be reused with minimal loss of activity. Additionally, we examined the distinct photodegradation mechanisms of pure BiYO3 and the CeO2/BiYO3 composite. Our results provide insights into how the formation of heterostructures influences photocatalytic processes. These findings are valuable for the future design and development of related heterostructure photocatalysts, aiming to enhance their efficiency for the degradation of various pollutants.
期刊介绍:
The Lancet Diabetes & Endocrinology, an independent journal with a global perspective and strong clinical focus, features original clinical research, expert reviews, news, and opinion pieces in each monthly issue. Covering topics like diabetes, obesity, nutrition, and more, the journal provides insights into clinical advances and practice-changing research worldwide. It welcomes original research advocating change or shedding light on clinical practice, as well as informative reviews on related topics, especially those with global health importance and relevance to low-income and middle-income countries. The journal publishes various content types, including Articles, Reviews, Comments, Correspondence, Health Policy, and Personal Views, along with Series and Commissions aiming to drive positive change in clinical practice and health policy in diabetes and endocrinology.